Close Menu
Home › Biomerieux Q3 Sales Up 7 Percent

Biomerieux Q3 Sales Up 7 Percent

Oct 20, 2016

NEW YORK (GenomeWeb) – Biomerieux reported today that its third quarter revenues rose 7 percent from Q3 2015, including a 46 percent jump in molecular biology sales.  

For the quarter ended Sept. 30, the company reported total revenues of €510.8 million ($557.3 million) from €478.3 million a year ago.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jul
30
Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

What's Popular?

In PCR

  1. Menarini to Distribute PlexBio IntelliPlex MDx System

  2. NeuMoDx Gets CE Mark on Hepatitis B and C Assays

  3. At ASM Microbe, Stakeholders Discuss Reimbursement Issues for Multiplex Infectious Disease Tests

    Premium

  4. AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy

  5. SpeeDx, GSK Sign Test Supply, Development Deal

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.